You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma in Situ

Showing 1 - 25 of 9,389
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pure Florid and Pleomorphic Lobular Carcinoma in Situ of Breast:

Recruiting
  • Pleomorphic Lobular Breast Carcinoma in Situ
  • Breast Florid Lobular Carcinoma in Situ
  • Surgical wide local excision
  • +4 more
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Nov 14, 2023

Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)

Not yet recruiting
  • Ductal Carcinoma in Situ
  • (no location specified)
Oct 13, 2023

Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy

Completed
  • Ductal Carcinoma in Situ
  • Mastectomy with sentinel lymph node biopsy
  • (no location specified)
Jul 17, 2023

Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)

Recruiting
  • Atypical Ductal Hyperplasia
  • Ductal Carcinoma in Situ
  • Vacuum-assisted excisional biopsy
  • Milan, Italy
    Breast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023

Ductal Carcinoma in Situ Trial in Durham (Decision Support Tool with Active Monitoring, Decision Support Tool without Active

Completed
Has Results
  • Ductal Carcinoma in Situ
  • Decision Support Tool with Active Monitoring
  • Decision Support Tool without Active Monitoring
  • Durham, North Carolina
    Duke Mammography Clinic
Jan 4, 2023

Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

Recruiting
  • Atypical Hyperplasia
  • Lobular Carcinoma in Situ
  • Evanston, Illinois
  • +1 more
Jan 20, 2023

Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

Not yet recruiting
  • Breast Atypical Hyperplasia
  • +3 more
  • Acolbifene Hydrochloride
  • +4 more
  • Duarte, California
  • +3 more
Jul 11, 2023

Breast Cancer Trial in Rozzano (external beams radiotherapy, brachytherapy)

Recruiting
  • Breast Cancer
  • external beams radiotherapy
  • brachytherapy
  • Rozzano, Milano, Italy
    IRCCS Istituto Clinico Humanitas
Jan 13, 2023

Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female Trial (Control Arm ACSM Guidelines, Experimental Arm 6-12-25

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Control Arm ACSM Guidelines
  • Experimental Arm 6-12-25 repetitions per set
  • (no location specified)
Nov 6, 2023

BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

Not yet recruiting
  • BRCA Mutation
  • +3 more
  • Tamoxifen 10 Mg Tablet
  • +2 more
  • Genoa, Italy
  • +3 more
Sep 11, 2023

Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +5 more
  • Intraoperative Imaging
  • Lumpectomy
  • Chicago, Illinois
  • +3 more
Nov 30, 2022

Squamous Cell Carcinoma in Situ Trial in United States (STP705, Placebo Saline)

Active, not recruiting
  • Squamous Cell Carcinoma in Situ
  • Scottsdale, Arizona
  • +5 more
Dec 13, 2022

Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ Trial in Boston, Quincy (Combination cream of 5-fluorouracil

Recruiting
  • Superficial Basal Cell Carcinoma
  • Squamous Cell Carcinoma in Situ
  • Combination cream of 5-fluorouracil and calcipotriene
  • 5-fluorouracil cream
  • Boston, Massachusetts
    Boston Medical Center Dermatology Clinic
Nov 9, 2022

MRI Characterization of Mammographically Detected DCIS

Recruiting
  • Breast Cancer, Stage 0
  • Breast MRI
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 21, 2022

Breast Cancer - Ductal Carcinoma in Situ (DCIS), Breast-Conserving Surgery Trial (Histolog Scanner)

Not yet recruiting
  • Breast Cancer - Ductal Carcinoma in Situ (DCIS)
  • Breast-Conserving Surgery
  • Histolog Scanner
  • (no location specified)
Jul 6, 2023

Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston

Completed
Has Results
  • Breast Atypical Ductal Hyperplasia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2022

Standard Breast Cancer Risk Assessment for African American and

Not yet recruiting
  • Breast Atypical Ductal Hyperplasia
  • +3 more
  • Biospecimen Collection
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Feb 22, 2023

Bladder Carcinoma in Situ (CIS) Trial (ONCOFID P-B (PACLITAXEL-HYALURONIC ACID))

Recruiting
  • Bladder Carcinoma in Situ (CIS)
  • ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)
  • New Orleans, Louisiana
    Ochsner Clinic Foundation
Jan 18, 2023

After Oncoplastic Breast Conserving Surgery

Not yet recruiting
  • Breast Cancer Stage I
  • +2 more
  • Breast-conserving surgery
  • (no location specified)
Feb 2, 2023

Breast Cancer, Carcinoma in Situ Trial in Kannur (Triage of clinical breast examination positive women using handheld ultrasound

Recruiting
  • Breast Cancer
  • Carcinoma in Situ
  • Triage of clinical breast examination positive women using handheld ultrasound by non-radiologists.
  • Kannur, India
    Malabar Cancer Care Society Kannur
Sep 28, 2023

Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation

Active, not recruiting
  • Breast Cancer
  • +4 more
  • External Beam Radiation Therapy
  • +2 more
  • Richmond, Virginia
  • +1 more
Dec 16, 2022

Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ Trial in Miami (APG-157)

Not yet recruiting
  • Oropharyngeal Dysplasia
  • +2 more
  • Miami, Florida
    University of Miami
May 9, 2023

Bowen's Disease, Cutaneous Squamous Cell Carcinoma in Situ Trial in Aventura (STP705)

Completed
  • Bowen's Disease
  • Cutaneous Squamous Cell Carcinoma in Situ
  • Aventura, Florida
    Center for Clinical and Cosmetic Research
Jun 8, 2022

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 17, 2023

DCIS Trial (Delay sentinel node biopsy)

Not yet recruiting
  • DCIS
  • Delay sentinel node biopsy
  • (no location specified)
Jun 12, 2023